162 related articles for article (PubMed ID: 8426467)
1. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review.
Secker-Walker LM; Craig JM
Leukemia; 1993 Feb; 7(2):147-51. PubMed ID: 8426467
[TBL] [Abstract][Full Text] [Related]
2. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
3. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance.
Secker-Walker LM; Craig JM; Hawkins JM; Hoffbrand AV
Leukemia; 1991 Mar; 5(3):196-9. PubMed ID: 2013979
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and molecular biological study of Ph positive acute leukemia: comparison with blast crisis of chronic myelogenous leukemia and Ph negative acute lymphoblastic leukemia].
Okada S; Shimizu T; Harada H; Miyoshi Y; Mori H; Niikura H; Omine M; Fujita K; Terada H
Rinsho Ketsueki; 1992 May; 33(5):646-54. PubMed ID: 1630016
[TBL] [Abstract][Full Text] [Related]
5. First intron and M-bcr breakpoints are restricted to the lymphoid lineage in Philadelphia positive acute lymphoblastic leukemia.
Craig JM; Hawkins JM; Yamada T; Ganeshaguru K; Mehta AB; Secker-Walker LM
Leukemia; 1990 Oct; 4(10):678-81. PubMed ID: 2214872
[TBL] [Abstract][Full Text] [Related]
6. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
[TBL] [Abstract][Full Text] [Related]
7. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia.
Ohyashiki JH; Ohyashiki K; Tauchi T; Saito M; Nakazawa S; Kimura N; Toyama K
Leukemia; 1990 Aug; 4(8):572-9. PubMed ID: 2143795
[TBL] [Abstract][Full Text] [Related]
9. Investigation of clonal involvement of myeloid cells in Philadelphia-positive and high hyperdiploid acute lymphoblastic leukemia.
Kasprzyk A; Harrison CJ; Secker-Walker LM
Leukemia; 1999 Dec; 13(12):2000-6. PubMed ID: 10602421
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
[TBL] [Abstract][Full Text] [Related]
11. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
[TBL] [Abstract][Full Text] [Related]
12. [Acute lymphoblastic leukemia with Philadelphia chromosome: eight case reports].
Laatiri MA; Chehata S; Amouri A; Sendi HS; Saad A; Ennabli S
Tunis Med; 2001 Jan; 79(1):38-41. PubMed ID: 11332342
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the translocation breakpoint in a patient with Philadelphia positive, bcr negative acute lymphoblastic leukaemia.
van der Feltz MJ; Shivji MK; Grosveld G; Wiedemann LM
Oncogene; 1988 Aug; 3(2):215-9. PubMed ID: 3166123
[TBL] [Abstract][Full Text] [Related]
15. [Ph1-positive leukemia: cytogenetic outline and prognosis].
Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
[TBL] [Abstract][Full Text] [Related]
16. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic findings in acute biphenotypic leukaemia.
Carbonell F; Swansbury J; Min T; Matutes E; Farahat N; Buccheri V; Morilla R; Secker-Walker L; Catovsky D
Leukemia; 1996 Aug; 10(8):1283-7. PubMed ID: 8709632
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations.
Huret JL; Brizard A; Slater R; Charrin C; Bertheas MF; Guilhot F; Hählen K; Kroes W; van Leeuwen E; Schoot EV
Leukemia; 1993 Feb; 7(2):152-60. PubMed ID: 8426468
[TBL] [Abstract][Full Text] [Related]
19. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
[TBL] [Abstract][Full Text] [Related]
20. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
